Evidence map›Paper›PMID 35291203›Full record

ArticleGlobal health & medicine2022

Proposal of new treatment algorithm for gastric cancer liver metastases: Up-front surgery or conversion surgery?

Nobuyuki Takemura, Akio Saiura, Hiromichi Ito, Kyoji Ito, Fuyuki Inagaki, Fuminori Mihara, Shusuke Yagi, Naoki Enomoto, Kyoko Nohara, Yosuke Inoue and 3 more

Abstract read
In one paragraph

Article in Global health & medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Practical management of oligometastatic gastric cancer.ESMO gastrointestinal oncology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Nobuyuki TakemuraDepartment of Surgery, Hepato-Biliary Pancreatic Surgery Division, National Center for Global Health and Medicine, Tokyo, Japan.
Akio SaiuraDepartment of Hepatobiliary Pancreatic Surgery, Juntendo University Hospital, Tokyo, Japan.
Hiromichi ItoDepartment of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Tokyo, Japan.
Kyoji ItoDepartment of Surgery, Hepato-Biliary Pancreatic Surgery Division, National Center for Global Health and Medicine, Tokyo, Japan.
Fuyuki InagakiDepartment of Surgery, Hepato-Biliary Pancreatic Surgery Division, National Center for Global Health and Medicine, Tokyo, Japan.
Fuminori MiharaDepartment of Surgery, Hepato-Biliary Pancreatic Surgery Division, National Center for Global Health and Medicine, Tokyo, Japan.
Shusuke YagiDepartment of Surgery, Upper Abdominal Surgery Division, National Center for Global Health and Medicine, Tokyo, Japan.
Naoki EnomotoDepartment of Surgery, Upper Abdominal Surgery Division, National Center for Global Health and Medicine, Tokyo, Japan.
Kyoko NoharaDepartment of Surgery, Upper Abdominal Surgery Division, National Center for Global Health and Medicine, Tokyo, Japan.
Yosuke InoueDepartment of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Tokyo, Japan.
Yu TakahashiDepartment of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Tokyo, Japan.
Kazuhiko YamadaDepartment of Surgery, Upper Abdominal Surgery Division, National Center for Global Health and Medicine, Tokyo, Japan.
Norihiro KokudoDepartment of Surgery, Hepato-Biliary Pancreatic Surgery Division, National Center for Global Health and Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatectomy for gastric cancer liver metastases (GCLM) has a 5-year survival rate of 9-42%; however, indications for hepatectomy remain unclear. Many researchers have reported prognostic factors for GCLM after hepatectomy, but surgical indications vary according to the literature. Furthermore, the indication for optimal candidates for neoadjuvant chemotherapy and intensive chemotherapy is also unclear. To understand the indications for surgery and chemotherapy intended for hepatectomy for GCLM, a new treatment algorithm was created based on previously reported evidence from the viewpoint of hepatic surgeons.

Indexed as

conversion surgerygastric cancer liver metastasestreatment algorithmup-front surgery

Identifiers

PMID35291203
PMCPMC8884038

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.